The effect of radio-adaptive doses on HT29 and GM637 cells

Silke B Schwarz^*¹ , Pamela M Schaffer^*¹ , Ulrike Kulka¹ , Birgit Ertl-Wagner² , Roswitha Hell¹ and Moshe Schaffer¹

¹Department of Radiation Oncology, Ludwig-Maximilians-University Munich, Marchioninistr. 15, 81377 Munich, Germany

²Institute of Clinical Radiology, Ludwig-Maximilians-University Munich, Marchioninistr. 15, 81377 Munich, Germany

author email corresponding author email* Contributed equally

Radiation Oncology 2008, 3:12doi:10.1186/1748-717X-3-12


Published:	23 April 2008

Abstract

Background

The shape of the dose-response curve at low doses differs from the linear quadratic model. The effect of a radio-adaptive response is the centre of many studies and well known inspite that the clinical applications are still rarely considered.

Methods

We studied the effect of a low-dose pre-irradiation (0.03 Gy – 0.1 Gy) alone or followed by a 2.0 Gy challenging dose 4 h later on the survival of the HT29 cell line (human colorectal cancer cells) and on the GM637 cell line (human fibroblasts).

Results

0.03 Gy given alone did not have a significant effect on both cell lines, the other low doses alone significantly reduced the cell survival. Applied 4 h before the 2.0 Gy fraction, 0.03 Gy led to a significant induced radioresistance in GM637 cells, but not in HT29 cells, and 0.05 Gy led to a significant hyperradiosensitivity in HT29 cells, but not in GM637 cells.

Conclusion

A pre-irradiation with 0.03 Gy can protect normal fibroblasts, but not colorectal cancer cells, from damage induced by an irradiation of 2.0 Gy and the application of 0.05 Gy prior to the 2.0 Gy fraction can enhance the cell killing of colorectal cancer cells while not additionally damaging normal fibroblasts. If these findings prove to be true in vivo as well this may optimize the balance between local tumour control and injury to normal tissue in modern radiotherapy.